These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12824528)

  • 1. Methods to study p53-repressed promoters.
    Dumont P; Della Pietra A; Murphy ME
    Methods Mol Biol; 2003; 234():111-20. PubMed ID: 12824528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
    Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
    Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromatin immunoprecipitation and its preliminary application for gene regulation].
    Zhang Y; Cheng XK; Wu NH; Shen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):52-5. PubMed ID: 15052775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO3 interacts with p53 and inhibits its transcriptional activity.
    Larsen S; Yokochi T; Isogai E; Nakamura Y; Ozaki T; Nakagawara A
    Biochem Biophys Res Commun; 2010 Feb; 392(3):252-7. PubMed ID: 19995558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system.
    Takada S; Kaneniwa N; Tsuchida N; Koike K
    Virology; 1996 Feb; 216(1):80-9. PubMed ID: 8615009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.
    Hublitz P; Kunowska N; Mayer UP; Müller JM; Heyne K; Yin N; Fritzsche C; Poli C; Miguet L; Schupp IW; van Grunsven LA; Potiers N; van Dorsselaer A; Metzger E; Roemer K; Schüle R
    Genes Dev; 2005 Dec; 19(23):2912-24. PubMed ID: 16322561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation and transrepression studies with p53.
    Scian MJ; Frum R; Deb SP; Deb S
    Methods Mol Biol; 2003; 234():93-110. PubMed ID: 12824527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
    Thomas S; Reisman D
    Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism for p53 to regulate its target gene ECK in signaling apoptosis.
    Jin YJ; Wang J; Qiao C; Hei TK; Brandt-Rauf PW; Yin Y
    Mol Cancer Res; 2006 Oct; 4(10):769-78. PubMed ID: 17050670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
    Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
    Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the p53 transcriptional activity.
    Liu G; Chen X
    J Cell Biochem; 2006 Feb; 97(3):448-58. PubMed ID: 16288459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.